Stockholders’ Equity - Schedule of Stock-Based Compensation Expense Included Within Research and Development, Professional Fees and General and Administrative Expenses (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Schedule of Stock-Based Compensation Expense Included Within Research and Development and General and Administrative Expenses [Line Items]
Stock-based compensation expense	$ 55,525	$ 7,054	$ 275,454	$ 520,404
Research and development [Member]
Schedule of Stock-Based Compensation Expense Included Within Research and Development and General and Administrative Expenses [Line Items]
Stock-based compensation expense		6,389		6,389
Professional fees [Member]
Schedule of Stock-Based Compensation Expense Included Within Research and Development and General and Administrative Expenses [Line Items]
Stock-based compensation expense	55,525		55,525
General and administrative [Member]
Schedule of Stock-Based Compensation Expense Included Within Research and Development and General and Administrative Expenses [Line Items]
Stock-based compensation expense		$ 665	$ 219,929	$ 514,015

Hoth Therapeutics, Inc. 10-Q